LU84031A1 - Mittel mit einem gehalt an einem lyophilisierten penicillinderivat - Google Patents

Mittel mit einem gehalt an einem lyophilisierten penicillinderivat Download PDF

Info

Publication number
LU84031A1
LU84031A1 LU84031A LU84031A LU84031A1 LU 84031 A1 LU84031 A1 LU 84031A1 LU 84031 A LU84031 A LU 84031A LU 84031 A LU84031 A LU 84031A LU 84031 A1 LU84031 A1 LU 84031A1
Authority
LU
Luxembourg
Prior art keywords
lyophilized
concentration
derivative
solution
penicillin derivative
Prior art date
Application number
LU84031A
Other languages
German (de)
English (en)
Inventor
B Haeger
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22935482&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU84031(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of LU84031A1 publication Critical patent/LU84031A1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU84031A 1981-03-26 1982-03-24 Mittel mit einem gehalt an einem lyophilisierten penicillinderivat LU84031A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24758681A 1981-03-26 1981-03-26
US24758681 1981-03-26

Publications (1)

Publication Number Publication Date
LU84031A1 true LU84031A1 (de) 1982-07-08

Family

ID=22935482

Family Applications (1)

Application Number Title Priority Date Filing Date
LU84031A LU84031A1 (de) 1981-03-26 1982-03-24 Mittel mit einem gehalt an einem lyophilisierten penicillinderivat

Country Status (23)

Country Link
JP (1) JPS57159708A (enrdf_load_stackoverflow)
AT (1) AT395533B (enrdf_load_stackoverflow)
AU (1) AU549784B2 (enrdf_load_stackoverflow)
BE (1) BE892541A (enrdf_load_stackoverflow)
CA (1) CA1209477A (enrdf_load_stackoverflow)
CH (1) CH652306A5 (enrdf_load_stackoverflow)
DE (2) DE3208505A1 (enrdf_load_stackoverflow)
DK (1) DK157976C (enrdf_load_stackoverflow)
ES (1) ES509234A0 (enrdf_load_stackoverflow)
FR (1) FR2502624B1 (enrdf_load_stackoverflow)
GB (1) GB2095551B (enrdf_load_stackoverflow)
GR (1) GR78386B (enrdf_load_stackoverflow)
HK (1) HK39189A (enrdf_load_stackoverflow)
HU (1) HU186489B (enrdf_load_stackoverflow)
IE (1) IE52936B1 (enrdf_load_stackoverflow)
IL (1) IL64924A (enrdf_load_stackoverflow)
IT (1) IT1147916B (enrdf_load_stackoverflow)
LU (1) LU84031A1 (enrdf_load_stackoverflow)
NL (1) NL192664C (enrdf_load_stackoverflow)
NZ (1) NZ199632A (enrdf_load_stackoverflow)
PL (1) PL130564B1 (enrdf_load_stackoverflow)
SE (1) SE453153B (enrdf_load_stackoverflow)
ZA (1) ZA82605B (enrdf_load_stackoverflow)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207661B1 (en) 1999-02-22 2001-03-27 Baxter International Inc. Premixed formulation of piperacillin sodium and tazobactam sodium injection
CA2543242C (en) 2003-10-23 2015-04-14 Otsuka Pharmaceutical Co., Ltd. Controlled release sterile freeze-dried aripiprazole formulation and injectable formulation thereof
ITMI20051630A1 (it) * 2005-09-02 2007-03-03 Acs Dobfar Spa Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi
MY152789A (en) 2007-07-31 2014-11-28 Otsuka Pharma Co Ltd Methods for producing aripiprazole suspension and freeze-dried formulation
CN114200057A (zh) * 2021-12-14 2022-03-18 坛墨质检科技股份有限公司 一种可替代标准溶液的抗生素类药物固体混合标准物质的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2608507A (en) * 1949-08-20 1952-08-26 Sharp & Dohme Inc Dialkyl sulfamyl benzoic acids
CH546783A (de) * 1971-03-11 1974-03-15 Hoffmann La Roche Verfahren zur herstellung von penicilloinsaeurederivate.
JPS5817728B2 (ja) * 1973-11-20 1983-04-09 山之内製薬株式会社 アンピシリンナトリウムエン ノ セイホウ
IL47168A (en) * 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
JPS52143221A (en) * 1976-05-22 1977-11-29 Yamanouchi Pharmaceut Co Ltd Novel preparations for rectal administration
DE2623835C2 (de) * 1976-05-28 1978-03-02 C.H. Boehringer Sohn, 6507 Ingelheim Verfahren zur Herstellung von Natriumampicillin
JPS542337A (en) * 1977-06-08 1979-01-09 Toyama Chem Co Ltd Bactericidal composition for medical use
FR2403078A1 (fr) * 1977-09-19 1979-04-13 Lafon Labor Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic
JPS54147917A (en) * 1978-05-08 1979-11-19 Sumitomo Chem Co Ltd Ferrze-drying method
PT70225A (en) * 1978-10-03 1979-10-01 Gist Brocades Nv Process for the preparation of sodium amoxicillin preparations
DE2925009A1 (de) * 1979-06-21 1981-01-08 Basf Ag Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung

Also Published As

Publication number Publication date
PL235509A1 (enrdf_load_stackoverflow) 1982-12-20
CH652306A5 (de) 1985-11-15
AU549784B2 (en) 1986-02-13
ATA92982A (de) 1992-06-15
IT1147916B (it) 1986-11-26
HU186489B (en) 1985-08-28
IE52936B1 (en) 1988-04-13
GB2095551B (en) 1984-10-03
FR2502624B1 (fr) 1985-10-25
DK48382A (da) 1982-09-27
SE453153B (sv) 1988-01-18
GR78386B (enrdf_load_stackoverflow) 1984-09-26
NL8201251A (nl) 1982-10-18
ES8302455A1 (es) 1982-12-16
DK157976B (da) 1990-03-12
GB2095551A (en) 1982-10-06
AU7986582A (en) 1982-09-30
CA1209477A (en) 1986-08-12
DE3208505A1 (de) 1982-10-21
ES509234A0 (es) 1982-12-16
DE19375106I2 (de) 2006-02-16
DK157976C (da) 1990-08-27
JPH0219804B2 (enrdf_load_stackoverflow) 1990-05-07
JPS57159708A (en) 1982-10-01
DE3208505C2 (enrdf_load_stackoverflow) 1991-11-28
ZA82605B (en) 1982-12-29
FR2502624A1 (fr) 1982-10-01
NL192664B (nl) 1997-08-01
IT8248034A0 (it) 1982-03-19
HK39189A (en) 1989-05-19
IL64924A0 (en) 1982-04-30
BE892541A (fr) 1982-09-20
SE8200591L (sv) 1982-09-27
AT395533B (de) 1993-01-25
IE820703L (en) 1982-09-26
NZ199632A (en) 1985-07-12
NL192664C (nl) 1997-12-02
PL130564B1 (en) 1984-08-31
IL64924A (en) 1985-07-31

Similar Documents

Publication Publication Date Title
DE3346123A1 (de) Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
DE68904922T2 (de) Piroxicam in waessrigen loesungen enthaltende arzneizubereitungen und verfahren zu deren herstellung.
DE2545973B2 (de) Verfahren zur Herstellung eines Digoxinarzneimittels in Form von therapeutischen Einzeldosen
EP0185210B1 (de) Verwendung von Dipeptidderivaten für die Herstellung von Arzneimitteln zur Behandlung von an amyotropher Lateralsklerose Erkrankten
DE69615984T2 (de) Verwendung von Ursolsäure zur Herstellung eines Arzneimittels zur Unterdrückung von Metastasen
EP1928459A2 (de) Tablettenförmige retardzubereitung enthaltend cinnarizin und dimenhydrinat gegen schwindel
DE69625200T2 (de) Arzneimittel enthaltend lamotrigin
DE69904727T2 (de) Injizierbares arzneimittel auf basis eines pharmazeutisch verträglichen salzes von clopidogrel bzw. von ticlopidin
DE2323187A1 (de) Verfahren zur herstellung einer stabilisierten, pulverfoermigen secretinzubereitung durch gefriertrocknung
DE69401502T2 (de) Arzneizubereitung zum Herstellen eines stabilisierten Pulvers das eine Kombination aus Acetylsalicylsäure und Metoclopramid als Wirkstoff enthält
DE2515001C2 (de) Prostaglandin enthaltende gefriergetrocknete Pulver
LU84031A1 (de) Mittel mit einem gehalt an einem lyophilisierten penicillinderivat
DE69431986T2 (de) Verwendung von granisetron zur behandlung von postoperativer übelkeit und erbrechen
DE60101979T2 (de) Lösung enthaltend N-[O-(p-pivaloyloxybenzenesulfonylamino)benzoyl]glyzin Mononatriumsalz Tetrahydrat und diese Lösung enthaltendes Arzneimittel
DE2719581A1 (de) Polyhydroxyphenylchromanone enthaltende arzneimittel
DE3324964C2 (enrdf_load_stackoverflow)
EP1021198A1 (de) Flavonolignan-zubereitungen, insbesondere silymarin-zubereitungen
DE19912436A1 (de) Ibuprofen-Lösung
DE1617638A1 (de) Tablettenbindemittel
DE2401450A1 (de) Pharmazeutische zusammensetzung zur linderung von hautproliferationserkrankungen
DE2117762A1 (de) Behandlung von Alopecia und pharmazeutische Präparation für die Durchführung der Behandlung
DE69132145T2 (de) Peritoneal wirksame medikamente
DE2013039A1 (de) Arzneimitteltablette zur oralen Verabreichung
Glanzmann Masern (Morbilli)
DE1965043A1 (de) Pharmazeutisch annehmbare Zubereitungen zur Anwendung an den Zaehnen